| Phase 3 |
| NCT06618664 |
A Clinical Study of SHR-8068 Combined With Adebrelimab and Bevacizumab Versus Sintilimab… |
Advanced Hepatocellular Carcinoma |
Recruiting |
| Phase 2 |
| NCT07309185 |
Adebrelimab Combined With Famitinib and Irinotecan in Advanced Gastric Cancer After… |
Stomach Neoplasms |
Recruiting |
| NCT07364305 |
HAIC Combined With Immune Therapy for Advanced, Non-Resectable ICC |
ICC |
Recruiting |
| NCT06610734 |
Multicenter, Phase II Randomized Controlled Study of Adebrelimab Combined With… |
Small Cell Lung Cancer Extensive Stage |
Recruiting |
| NCT07437898 |
Neoadjuvant Adebrelimab Plus Chemotherapy for Esophageal Cancer: A Clinical Study |
Esophageal Squamous Cell Carcinoma |
Recruiting |
| NCT06885814 |
Efficacy and Safety of Adebrelimab Combined With Chemoradiotherapy in Patients With… |
Esophageal Squamous Cell Carcinoma |
Recruiting |
| NCT07353684 |
Adebrelimab Plus Apatinib Combined With SOX Regimen as Conversion Therapy for Gastric… |
Adebrelimab |
Recruiting |
| NCT07241793 |
Phase II Study of Trastuzumab Rezetecan or in Combination With Adebrelimab in… |
Urothelial Carcinoma |
Recruiting |
| NCT07569679 |
Alternating HAIC and Systemic Chemotherapy With or Without Adebrelimab and Apatinib for… |
Biliary Tract Cancer |
Recruiting |
| NCT05582499 |
Fudan University Shanghai Cancer Center Breast Cancer Precision Platform Series Study… |
Breast Neoplasm |
Recruiting |
| NCT06339619 |
Combination Immunotherapy of Adebrelimab With Apatinib and Tegafur, Gimeracil and… |
Locally Advanced or Metastatic Esophageal Squamous Cell Carcinoma |
Recruiting |
| NCT07317778 |
Chemotherapy With or Without Adebrelimab and T-DXh as Neoadjuvant Therapy for HR+/HER2… |
Breast Cancer Early Stage Breast Cancer (Stage 1-3) |
Not Yet Recruiting |
| NCT07327411 |
Cetuximab β Combined With PRaG Regimen in the Treatment of EGFR-positive Advanced… |
Advanced Refractory Solid Tumors |
Not Yet Recruiting |
| NCT07266025 |
Adebrelimab Combined With Induction Chemotherapy or SHR-8068 for Mismatch… |
Gastric Adenocarcinoma |
Not Yet Recruiting |
| NCT07398560 |
Adebrelimab Combined With Oral Etoposide for Elderly Patients and Patients With Poor… |
Small Cell Lung Cancer |
Not Yet Recruiting |
| NCT07466927 |
Study of Multi-mode Thermal Therapy Combined With Immunotherapy In Patients With… |
HER2-negative Breast Cancer |
Not Yet Recruiting |
| NCT07543783 |
Efficacy and Safety of Low-dose Bevacizumab Plus Adebrelimab Combined With Transarterial… |
Adebrelimab (SHR-1316) |
Not Yet Recruiting |
| NCT07554768 |
Neoadjuvant Radio-immunotherapy Versus Immunotherapy Alone for Locally Advanced HNSCC |
Head and Neck Squamous Cell Carcinoma |
Not Yet Recruiting |
| NCT07561775 |
Adebrelimab Plus S-1 for Resected Cholangiocarcinoma |
Cholangiocarcinoma |
Not Yet Recruiting |
| NCT07583550 |
Low-dose Thoracic Radiotherapy Followed by Adebrelimab Plus Chemotherapy, and Then… |
Lung |
Not Yet Recruiting |
| NCT06465563 |
SHR-8068 in Combination With Adebrelimab, Bevacizumab, and Platinum-Based Chemotherapy as… |
Biliary Tract Cancer |
Active, Not Recruiting |
| Phase 1/2 |
| NCT07392541 |
Adebrelimab Combined With Gemcitabine, Cisplatin, and Simvastatin for Advanced Biliary… |
Advanced Biliary Tract Carcinoma |
Recruiting |
| NCT06427239 |
Exploratory Clinical Study of HRS-4642 Combined With Adebrelimab in the Treatment of… |
Pancreatic Cancer |
Recruiting |
| Not specified |
| NCT07434518 |
A Real-World Study Evaluating the Efficacy and Safety of Adebrelimab in Patients With… |
Small Cell Lung Cancer (SCLC) |
Recruiting |
| NCT07640048 |
Adjuvant Therapy for High-Risk Intrahepatic Cholangiocarcinoma: A Real-World Study |
Intrahepatic Cholangiocarcinoma (Icc) |
Recruiting |